Stock Opinions by Kevin Simpson

Most recent Opinions go here

Be up to date, don't miss your chance.

BUY

He added more. Earnings were very good. New therapies have been adding to margins. They beat top and bottom lines and raised guidance. Will hold for a long time.

BUY

Was upgraded today. He added to it last week. It doesn't need a multiple expansion to recover. The PE is below 20x, cheap. It's about content, which has lagged and needs to improve. He thinks it will.

TRADE

He had covered calls until their report last week blew it out of the water, exceeding anything he could dream of. So, he wrote a $530 call which expires in a couple weeks. He's harvesting some volatility without any loss of conviction in the name.

BUY

He bought more at $218 to own for a long time. He expects a great report (in 2 weeks) and a big move up before that. They are the OG. They make more and more money everyday, but don't see the love in the share price.

PARTIAL SELL

Was downgraded today. Margins are falling. But the stock has been on a tear the past year. Okay to take some profits now, but not sell all.

BUY

Was upgraded today. It's the highest-quality healthcare stock. They have more than just the GLP-1 drug; are diverse with their entire drug catalogue. Exceptional execution. Good PE. 

COMMENT

There's a lot of money going into it. There are 2.5 billion Apple devices in the world is no joke. And they could deliver AI in them. There's room to run. He wrote a covered call at a $350 strike; if it stalls here a bit, he gets paid an options premium. He loves it. He's been in and out of it for 15 years. Likes the coming cycle: the flip phone, prospects in China. Apple Intelligence is just getting started which can help with a multi-year upgrade cycle.

DON'T BUY

The buzz shows that people are watching now like House of the Dragon are not on Netflix. NFLX needs better content, though live sports is the easy answer like Monday Night Football. He sold his shares a few days ago.

BUY

A disciplined capital allocator. Have a fortress balance sheet, are growing and the dividend keeps rising.

BUY

He added shares. It's in its maturity process, like Apple in the past. He considers his a long-term investment. They're buying back $80 billion in shares and pay a 0.5% dividend. They attain nearly $100 billion of revenue per quarter. Is a good time to buy.

BUY

He just bought it as a new buy. For 2 years, there's been criticism of their AI spend, but recently they've gone from blindly spending to a path to revenue though isn't sure if their new Spark 1.1 will be profitable. But they can sell some of their space within their compute, which makes them a competitor to Google and Amazon. He likes how they're branching beyond an ad company.

BUY ON WEAKNESS

He'd like to this and Tesla merge. There would be great synergies. Both companies trade at high multiples and volatilty. If it falls to $100, he will double down.

BUY ON WEAKNESS

It's not just an AI story, it's also power generation, mining, and infrastructure. It's a multi-year play. Shares are up 65% this year. It's price to perfection now and would buy it only on weakness.

DON'T BUY

Was downgraded today. Demand for Pepsi in North America has been terrible. It's a small position for him. Is -5% this year. Coke is up 20%.

BUY

Blackwell continues to outpace; demand is unbelievable and are now approaching $100 billion per quarter.

Showing 1 to 15 of 197 entries